rs4986782
Variant in the NAT1 gene (N-Acetyltransferase 1)
rs4986782 is a single nucleotide polymorphism (SNP) in the NAT1 gene, involved in arylamine N-acetyltransferase / drug metabolism. Variants at this position have been studied in relation to immune function, metabolism, and chronic illness.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is the rs4986782 variant?
rs4986782 is a SNP (single nucleotide polymorphism) in the NAT1 (N-Acetyltransferase 1) gene. It belongs to the Pharmacogenomics category and is part of the Detox & Medication Sensitivity biological cluster. NAT1 encodes N-acetyltransferase 1, which acetylates arylamine drugs and endogenous compounds in many tissues.
Biological role and pathway
This variant sits within the NAT1 gene, which is involved in the arylamine N-acetyltransferase / drug metabolism pathway. Genes within the Detox & Medication Sensitivity cluster work together to maintain balanced function across interconnected biological systems.
Variants in genes within this pathway may influence an individual's predisposition to altered function — particularly under conditions of physiological stress such as viral infection or prolonged illness.
rs4986782 and Long COVID / ME-CFS research
NAT1 activity affects drug acetylation; variants may influence metabolism of drugs used in Long COVID management.
This information is based on published research and does not constitute medical advice. See references below.
Parent gene: NAT1
rs4986782 is one of 2 known variants in the NAT1 gene. To understand the full biological context of this variant, explore the parent gene page.
View NAT1 gene page →Conditions studied in relation to rs4986782
Research into NAT1 variants including rs4986782 has explored associations with the following conditions. These are areas of scientific investigation and do not imply causation.
Genetic insights from DNA data
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include NAT1 and the rs4986782 variant.
The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.
Other variants in the NAT1 gene
The following variants in NAT1 are also studied in relation to chronic illness and may be analysed together for a more complete picture.
Frequently asked questions
What is the rs4986782 variant in the NAT1 gene?
rs4986782 is a single nucleotide polymorphism (SNP) located in the NAT1 (N-Acetyltransferase 1) gene, which is involved in arylamine N-acetyltransferase / drug metabolism. NAT1 encodes N-acetyltransferase 1, which acetylates arylamine drugs and endogenous compounds in many tissues.
How may the rs4986782 variant relate to Long COVID or ME/CFS?
NAT1 activity affects drug acetylation; variants may influence metabolism of drugs used in Long COVID management.
Can a consumer DNA test detect the rs4986782 variant?
Many consumer DNA tests such as 23andMe, AncestryDNA, and MyHeritage genotype common SNPs. ChronicDNA analyses your raw DNA file and reports on variants studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.
Find out if you carry the rs4986782 variant
Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
References
The following publications were used in compiling the research context for NAT1 and its variants. This is not an exhaustive literature review.
- [1]PMID: 32296168
- [2]Nature Genetics
- [3]Pharmacogenomics